Stocktoria
Nexentis Technologies Inc. NXTS
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2010-05-26
Nexentis Technologies Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | — | 21.4% | 79.0% | 59.8% | 69.0% | 81.3% | 17.8% | 74.0% |
| Operating margin | — | -1563.3% | -2876.5% | -1477.1% | -1073.5% | -580.9% | -1098.4% | -121.6% |
| Net margin | — | -2472.9% | -2475.7% | -1456.7% | -1100.2% | -685.9% | -1121.3% | -83.7% |
| FCF margin | — | — | — | -1306.8% | -954.3% | — | -721.2% | -119.3% |
| Return on assets | -19.6% | -95.0% | -90.0% | -88.4% | -63.5% | -231.7% | -296.6% | -41.5% |
| Return on equity | -25.0% | -109.3% | -100.6% | -98.2% | -74.4% | 342.3% | 490.3% | -163.5% |
| Debt / equity | — | — | — | — | 0.00× | -0.03× | -0.06× | 0.28× |
| Current ratio | 4.19 | 3.87 | 7.02 | 8.77 | 7.76 | 0.63 | 0.68 | 1.40 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.